Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Rev Med Inst Mex Seguro Soc ; 61(Suppl 2): S171-S177, 2023 09 18.
Article in Spanish | MEDLINE | ID: mdl-38011646

ABSTRACT

Background: Critically ill newborns (NB) are susceptible to serious complications due to their immature immune system. Objective: To know the prognostic utility of inflammatory indexes in critically ill NBs. Material and methods: Observational, analytical, longitudinal, prospective study. We included NBs hospitalized, critically ill and non-critically ill, who had a complete blood count at 12 hours of life (initial) and within 24 hours prior to discharge due to improvement or death (final). Systemic immune-inflammatory Index (SII), Neutrophil/Lymphocyte Ratio (NLR) and Platelets/Lymphocyte Ratio (PLR) were analyzed. There was follow-up from birth to discharge. Results: 211 patients of 33 (32-34) weeks of gestation, weight 1.569 (1.480-1.720) kg. 106 critical NB and 105 non-critical NB, with 50 deaths in the former group, were analyzed. The final NLR ≥ 1.38 (sensitivity [S] 58%, specificity [Sp] 58%, AUC 0.60 [p 0.006]) identified critically ill NBs compared to non-critical ill NBs; final NLR ≥ 1.84 (S 71%, Sp 71%, AUC 0.79 [p < 0.0001]) identified critically ill NBs who died compared to all those who survived; final SII ≥ 255.411 x 103 (S 55%, Sp 56%, AUC 0.60 [p 0.047]) and final NLR ≥ 1.75 (S 76%, Sp 76%, AUC 0.84 [p < 0.0001]) identified critical NBs who died from those who survived. Conclusion: The final NLR predicts which NBs may perish with respect to all who survive. The final NLR and SII predict among critically ill NBs who may die.


Introducción: los recién nacidos (RN) críticamente enfermos son susceptibles de mal pronóstico debido a su sistema inmunitario inmaduro. Objetivo: conocer la utilidad pronóstica de los índices inflamatorios en RN críticamente enfermos. Material y métodos: estudio observacional, analítico, longitudinal, prospectivo. Incluimos RN hospitalizados, críticamente enfermos y no críticos, que contaran con biometría hemática completa a las 12 horas de vida (inicial) y dentro de las 24 horas previas al egreso por mejoría o defunción (final). Se analizó el Índice inmunosistémico (IIS), neutrófilos linfocitos (INL) y plaquetas linfocitos (IPL). Hubo seguimiento desde el nacimiento hasta el egreso. Resultados: se analizaron 211 pacientes, de 33 (32-34) semanas de gestación, peso 1.569 (1.480-1.720) kg; 106 RN críticos y 105 no críticos, con 50 defunciones en los primeros. El INL final ≥ 1.38 (sensibilidad [S] 58%, especificidad [E] 58%, ABC 0.60 [p 0.006]) identificó RN críticamente enfermos con respecto a RN no críticos; INL final ≥1.84 (S 71%, E 71%, ABC 0.79 [p < 0.0001]) identificó RN críticamente enfermos que fallecieron con respecto a todos los que sobrevivieron; el IIS final ≥ 255.411 x 103 (S 55%, E 56%, ABC 0.60 [p 0.047]) e INL final ≥ 1.75 (S 76%, E 76%, ABC 0.84 [p < 0.0001]) identificaron a RN críticamente enfermos que fallecieron con respecto a los que sobrevivieron. Conclusiones: el INL final predice que RN pueden fallecer con respecto a todos los que sobreviven. El INL y el IIS finales predicen entre los RN críticamente enfermos quiénes pueden fallecer.


Subject(s)
Critical Illness , Inflammation , Infant, Newborn , Humans , Prognosis , Prospective Studies , Lymphocytes , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...